A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type

A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type

Background: A phase II study of methotrexate, etoposide, dexamethasone, and pegaspargase (MESA) sandwiched with radiotherapy for newly diagnosed, stage IE-IIE extranodal natural-killer/T-cell lymphoma, nasal-type (ENKTL) was conducted to explore its clinical efficacy and safety, as well as novel ser...

Full description

Bibliographic Details
Main Authors:	Peng-Peng Xu, Jie Xiong, Shu Cheng, Xia Zhao, Chao-Fu Wang, Gang Cai, Hui-Juan Zhong, Heng-Ye Huang, Jia-Yi Chen, Wei-Li Zhao
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	EBioMedicine
Subjects:	Extranodal natural-killer/T-cell lymphoma, nasal type Asparaginase Metabolomic profile Prognosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417304024

Similar Items

Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type
by: Shu Tian, et al.
Published: (2019-07-01)

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
by: Liu WJ, et al.
Published: (2018-10-01)

Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study
by: Liu T, et al.
Published: (2018-10-01)

Extranodal Natural Killer/T-Cell Lymphoma of the Nasal Type with Skin Metastases
by: Fadi Al Akhrass, et al.
Published: (2016-01-01)

Extranodal NK/T-cell lymphoma-nasal type: Experience from a regional cancer center in India
by: Smitha Carol Saldanha, et al.
Published: (2020-01-01)

Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type
by: Tong Q, et al.
Published: (2018-06-01)

Skin lesion of extranodal natural killer/T‐cell lymphoma nasal type
by: Koichiro Okumura, et al.
Published: (2021-09-01)

Extranodal natural killer/T-cell lymphoma, nasal type, presenting with acneiform eruptions: A previously undescribed variant
by: Chen-Pu Yeh, et al.
Published: (2020-01-01)

Extranodal natural killer/T-cell lymphoma with paraneoplastic eosinophilic myositis
by: Jayati Mallick, et al.
Published: (2020-09-01)

Extranodal natural killer/T‐cell lymphoma in an 11‐year‐old child
by: Takeshi Ninchoji, et al.
Published: (2020-12-01)

Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma
by: Lin-Shu Zeng, et al.
Published: (2017-12-01)

Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
by: Ningning Yao, et al.
Published: (2020-06-01)

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome
by: Na Li, et al.
Published: (2021-08-01)

PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity
by: Wen Zheng, et al.
Published: (2018-09-01)

Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis
by: Li J, et al.
Published: (2020-12-01)

Linfoma Extranodal de Células NK/T tipo Nasal Extranodal Nasal type NK/T-Cell Lymphoma
by: Carlos S. Chiattone
Published: (2009-08-01)

Primary NK/T cell lymphoma nasal type of the colon
by: Ana María Chirife, et al.
Published: (2013-02-01)

Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study
by: Liqiang Wei, et al.
Published: (2020-08-01)

Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma
by: Shao-Qing Niu, et al.
Published: (2016-04-01)

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
by: Wang L, et al.
Published: (2016-09-01)

Cutaneous extranodal natural killer/T-cell lymphoma mimicking cellulitis: A unique presentation
by: Ali Duffens, BS, et al.
Published: (2020-12-01)

Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review
by: Bender C, et al.
Published: (2021-04-01)

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma
by: He Huang, et al.
Published: (2020-09-01)

Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study
by: Ya-Jun Li, et al.
Published: (2017-07-01)

Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III–IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus
by: Zhao Q, et al.
Published: (2019-04-01)

Extranodal Natural Killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma.’ A case report
by: Tlholoe Martha M, et al.
Published: (2013-01-01)

A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy
by: Lam ST, et al.
Published: (2020-03-01)

Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature
by: Zhe-Sheng Chen, et al.
Published: (2021-08-01)

Acute respiratory distress syndrome emerging after surgical debridement in a patient with extranodal natural killer/T cell lymphoma
by: Wei Wang, et al.
Published: (2021-01-01)

The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study
by: Li J, et al.
Published: (2021-02-01)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
by: Zuhaimy, Hanis, et al.
Published: (2017-02-01)

Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type
by: Quan Q, et al.
Published: (2016-03-01)

Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma
by: Young-In Maeng, et al.
Published: (2021-07-01)

Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
by: Hongyan Li, et al.
Published: (2021-01-01)

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis
by: Atif Saleem, et al.
Published: (2020-02-01)

Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
by: Zhao Xue, et al.
Published: (2018-08-01)

Regional Brain Glucose Metabolism and Its Prognostic Value in Pretreatment Extranodal Natural Killer/T-Cell Lymphoma Patients
by: Zhou Z, et al.
Published: (2021-05-01)

Primary adrenal extranodal NK/T-cell lymphoma: A case report and literature review
by: Satoshi Ichikawa, et al.
Published: (2020-01-01)

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review
by: Seok Jin Kim, et al.
Published: (2018-12-01)

A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy
by: Qian M, et al.
Published: (2017-07-01)